“Polypill” to fight cardiovascular disease: Cost effectiveness of statins for primary prevention of cardiovascular events is questionable
AUTOR(ES)
Messori, Andrea
FONTE
BMJ Publishing Group Ltd.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=214164Documentos Relacionados
- “Polypill” to fight cardiovascular disease: Authors' reply
- “Polypill” to fight cardiovascular disease: Patients before populations
- “Polypill” to fight cardiovascular disease: Interpretation of trial data is optimistic
- “Polypill” to fight cardiovascular disease: Summary of rapid responses
- “Polypill” to fight cardiovascular disease: Now who's playing God?